BioCentury | Dec 2, 2016
Company News
OpGen, Merck deal
...OpGen will perform genomic analysis, drug resistance testing and input the results into its Acuitas Lighthouse...
...OpGen will have rights to genomic IP, and the pharma will have access to OpGen's Lighthouse...
...OpGen will have rights to genomic IP, and the pharma will have access to OpGen's Lighthouse...